Literature DB >> 23837760

Selectively starving cancer cells through dietary manipulation: methods and clinical implications.

Brittany A Simone1, Colin E Champ, Anne L Rosenberg, Adam C Berger, Daniel A Monti, Adam P Dicker, Nicole L Simone.   

Abstract

As the link between obesity and metabolic syndrome and cancer becomes clearer, the need to determine the optimal way to incorporate dietary manipulation in the treatment of cancer patients becomes increasingly important. Metabolic-based therapies, such as caloric restriction, intermittent fasting and a ketogenic diet, have the ability to decrease the incidence of spontaneous tumors and slow the growth of primary tumors, and may have an effect on distant metastases in animal models. Despite the abundance of preclinical data demonstrating the benefit of dietary modification for cancer, to date there are few clinical trials targeting diet as an intervention for cancer patients. We hypothesize that this may be due, in part, to the fact that several different types of diet modification exist with no clear recommendations regarding the optimal method. This article will delineate three commonly used methods of dietary manipulation to assess the potential of each as a regimen for cancer therapy.

Entities:  

Mesh:

Year:  2013        PMID: 23837760     DOI: 10.2217/fon.13.31

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  29 in total

1.  In reply.

Authors:  Colin E Champ; Nicole L Simone
Journal:  Oncologist       Date:  2013

2.  Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme.

Authors:  Colin E Champ; Joshua D Palmer; Jeff S Volek; Maria Werner-Wasik; David W Andrews; James J Evans; Jon Glass; Lyndon Kim; Wenyin Shi
Journal:  J Neurooncol       Date:  2014-01-19       Impact factor: 4.130

3.  Pilot Study to Explore the Accuracy of Current Prediction Equations in Assessing Energy Needs of Patients with Newly Diagnosed Glioblastoma Multiforme.

Authors:  Rebecca B Little; Robert A Oster; Betty E Darnell; Wendy Demark-Wahnefried; L Burt Nabors
Journal:  Nutr Cancer       Date:  2016-06-24       Impact factor: 2.900

4.  Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer.

Authors:  Brittany A Simone; Tu Dan; Ajay Palagani; Lianjin Jin; Sunny Y Han; Christopher Wright; Jason E Savage; Robert Gitman; Meng Kieng Lim; Juan Palazzo; Minesh P Mehta; Nicole L Simone
Journal:  Cell Cycle       Date:  2016-03-30       Impact factor: 4.534

Review 5.  Employing proteomics to understand the effects of nutritional intervention in cancer treatment.

Authors:  Monica M Schroll; Amanda B Hummon
Journal:  Anal Bioanal Chem       Date:  2018-07-04       Impact factor: 4.478

6.  Roles of caloric restriction, ketogenic diet and intermittent fasting during initiation, progression and metastasis of cancer in animal models: a systematic review and meta-analysis.

Authors:  Mengmeng Lv; Xingya Zhu; Hao Wang; Feng Wang; Wenxian Guan
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

7.  A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer.

Authors:  Caroline W Cohen; Kevin R Fontaine; Rebecca C Arend; Ronald D Alvarez; Charles A Leath; Warner K Huh; Kerri S Bevis; Kenneth H Kim; John M Straughn; Barbara A Gower
Journal:  J Nutr       Date:  2018-08-01       Impact factor: 4.798

8.  Cancer Treatment With the Ketogenic Diet: A Systematic Review and Meta-analysis of Animal Studies.

Authors:  Jing Li; Haiyan Zhang; Zhu Dai
Journal:  Front Nutr       Date:  2021-06-09

Review 9.  Cancer as a metabolic disease: implications for novel therapeutics.

Authors:  Thomas N Seyfried; Roberto E Flores; Angela M Poff; Dominic P D'Agostino
Journal:  Carcinogenesis       Date:  2013-12-16       Impact factor: 4.944

Review 10.  Calories, carbohydrates, and cancer therapy with radiation: exploiting the five R's through dietary manipulation.

Authors:  Rainer J Klement; Colin E Champ
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.